236 related articles for article (PubMed ID: 22941044)
1. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR).
Brouillet S; Murthi P; Hoffmann P; Salomon A; Sergent F; De Mazancourt P; Dakouane-Giudicelli M; Dieudonné MN; Rozenberg P; Vaiman D; Barbaux S; Benharouga M; Feige JJ; Alfaidy N
Cell Mol Life Sci; 2013 Feb; 70(3):511-25. PubMed ID: 22941044
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors.
Brouillet S; Hoffmann P; Chauvet S; Salomon A; Chamboredon S; Sergent F; Benharouga M; Feige JJ; Alfaidy N
Cell Mol Life Sci; 2012 May; 69(9):1537-50. PubMed ID: 22138749
[TBL] [Abstract][Full Text] [Related]
3. NLRP7 is increased in human idiopathic fetal growth restriction and plays a critical role in trophoblast differentiation.
Abi Nahed R; Reynaud D; Borg AJ; Traboulsi W; Wetzel A; Sapin V; Brouillet S; Dieudonné MN; Dakouane-Giudicelli M; Benharouga M; Murthi P; Alfaidy N
J Mol Med (Berl); 2019 Mar; 97(3):355-367. PubMed ID: 30617930
[TBL] [Abstract][Full Text] [Related]
4. PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development.
Garnier V; Traboulsi W; Salomon A; Brouillet S; Fournier T; Winkler C; Desvergne B; Hoffmann P; Zhou QY; Congiu C; Onnis V; Benharouga M; Feige JJ; Alfaidy N
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E357-69. PubMed ID: 26081281
[TBL] [Abstract][Full Text] [Related]
5. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.
Hoffmann P; Feige JJ; Alfaidy N
Endocrinology; 2006 Apr; 147(4):1675-84. PubMed ID: 16384869
[TBL] [Abstract][Full Text] [Related]
6. EG-VEGF Induces Invasion of a Human Trophoblast Cell Line via PROKR2.
Tani K; Mitsui T; Mishima S; Ohira A; Maki J; Eto E; Hayata K; Nakamura K; Masuyama H
Acta Med Okayama; 2021 Dec; 75(6):677-684. PubMed ID: 34955534
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells.
Brouillet S; Hoffmann P; Benharouga M; Salomon A; Schaal JP; Feige JJ; Alfaidy N
Mol Biol Cell; 2010 Aug; 21(16):2832-43. PubMed ID: 20587779
[TBL] [Abstract][Full Text] [Related]
8. Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
Lappas M; McCracken S; McKelvey K; Lim R; James J; Roberts CT; Fournier T; Alfaidy N; Powell KL; Borg AJ; Morris JM; Leaw B; Singh H; Ebeling PR; Wallace EM; Parry LJ; Dimitriadis E; Murthi P
Mol Hum Reprod; 2018 Feb; 24(2):94-109. PubMed ID: 29272530
[TBL] [Abstract][Full Text] [Related]
9. The role of insulin-like growth factor 2 receptor-mediated homeobox gene expression in human placental apoptosis, and its implications in idiopathic fetal growth restriction.
Harris LK; Pantham P; Yong HEJ; Pratt A; Borg AJ; Crocker I; Westwood M; Aplin J; Kalionis B; Murthi P
Mol Hum Reprod; 2019 Sep; 25(9):572-585. PubMed ID: 31418778
[TBL] [Abstract][Full Text] [Related]
10. Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition.
Dunand C; Hoffmann P; Sapin V; Blanchon L; Salomon A; Sergent F; Benharouga M; Sabra S; Guibourdenche J; Lye SJ; Feige JJ; Alfaidy N
Biol Reprod; 2014 Sep; 91(3):73. PubMed ID: 25122063
[TBL] [Abstract][Full Text] [Related]
11. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.
Benlahfid M; Traboulsi W; Sergent F; Benharouga M; Elhattabi K; Erguibi D; Karkouri M; Elattar H; Fadil A; Fahmi Y; Aboussaouira T; Alfaidy N
Cancer Biomark; 2018 Feb; 21(2):345-354. PubMed ID: 29226856
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
13. Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction.
Rajaraman G; Murthi P; Pathirage N; Brennecke SP; Kalionis B
Am J Pathol; 2010 Jan; 176(1):278-87. PubMed ID: 20008130
[TBL] [Abstract][Full Text] [Related]
14. Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunction.
Borg AJ; Yong HE; Lappas M; Degrelle SA; Keogh RJ; Da Silva-Costa F; Fournier T; Abumaree M; Keelan JA; Kalionis B; Murthi P
Reproduction; 2015 May; 149(5):523-32. PubMed ID: 25713425
[TBL] [Abstract][Full Text] [Related]
15. Prokineticin1 and pregnancy.
Alfaidy N
Ann Endocrinol (Paris); 2016 Jun; 77(2):101-4. PubMed ID: 27172869
[TBL] [Abstract][Full Text] [Related]
16. Homeobox gene Distal-less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction.
Chui A; Tay C; Cocquebert M; Sheehan P; Pathirage NA; Donath S; Fournier T; Badet J; Evain-Brion D; Brennecke SP; Kalionis B; Murthi P
J Mol Med (Berl); 2012 Mar; 90(3):273-84. PubMed ID: 22113468
[TBL] [Abstract][Full Text] [Related]
17. Sustained Endocrine Gland-Derived Vascular Endothelial Growth Factor Levels Beyond the First Trimester of Pregnancy Display Phenotypic and Functional Changes Associated With the Pathogenesis of Pregnancy-Induced Hypertension.
Sergent F; Hoffmann P; Brouillet S; Garnier V; Salomon A; Murthi P; Benharouga M; Feige JJ; Alfaidy N
Hypertension; 2016 Jul; 68(1):148-56. PubMed ID: 27141059
[TBL] [Abstract][Full Text] [Related]
18. The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.
Alfaidy N; Hoffmann P; Boufettal H; Samouh N; Aboussaouira T; Benharouga M; Feige JJ; Brouillet S
Biomed Res Int; 2014; 2014():451906. PubMed ID: 24955357
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression
Traboulsi W; Sergent F; Boufettal H; Brouillet S; Slim R; Hoffmann P; Benlahfid M; Zhou QY; Balboni G; Onnis V; Bolze PA; Salomon A; Sauthier P; Mallet F; Aboussaouira T; Feige JJ; Benharouga M; Alfaidy N
Clin Cancer Res; 2017 Nov; 23(22):7130-7140. PubMed ID: 28899975
[No Abstract] [Full Text] [Related]
20. Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.
Su MT; Lin SH; Chen YC; Kuo PL
Fertil Steril; 2014 Oct; 102(4):1071-1077.e3. PubMed ID: 25064403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
